Our Platform
Neomera builds high-resolution protein interaction landscapes across proteins, peptides, and biologics. We generate the labels modern protein ML models and discovery teams actually need — especially for difficult targets.
What current protein-interaction data is missing
Most public protein-interaction data is positive-biased. Better models need richer labels.
What Neomera adds
- True negatives
- Within-family selectivity
- Native-conformation labels
- Difficult target coverage
Built for the targets and labels others miss
Membrane proteins, GPCRs, and ion channels measured in native-like conformations.
Non-binders define the decision boundary.
Differentiate subtype-selective interactions from family-level binding.
Core and follow-on assays stay comparable end-to-end.
Coverage
We support proteins, peptides, and biologics, including GPCRs, cytokines, enzymes, kinases, peptide therapeutics, antibodies, protein-protein interactions, and protein-peptide interactions.
Membrane proteins are where differentiation is strongest — and unmet need is greatest.
